-defensin CNV is not associated with susceptibility to Candida albicans infections in Sardinian APS I patients

The aim of this study was to investigate whether a variation in the genomic copy number (CNV) of the -defensin cluster could be associated with the pre-disposition to chronic mucocutaneous candidiasis (CMC) in Sardinian APECED patients.